BNP Paribas Asset Management
AVNS

BNP Paribas Asset Management’s Avanos Medical AVNS Stock Holding History

BNP Paribas Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.3K Buy
1,665
+490
+42% +$6.6K ﹤0.01% 1983
2025
Q4 		$13K Buy
1,175
+308
+36% +$3.52K ﹤0.01% 2066
2025
Q3 		$10K Buy
867
+250
+41% +$2.93K ﹤0.01% 1620
2025
Q2 		$8K Buy
+617
New +$7.76K ﹤0.01% 1835

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

BNP Paribas Asset Management's AVNS Position: Q1 2026 in Review

BNP Paribas Asset Management increased its Avanos Medical (AVNS) stake by 42% in Q1 2026, buying an estimated $6.6K and bringing the position to 1,665 shares worth $23.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1983.

BNP Paribas Asset Management first reported a position in AVNS in Q2 2025 and has held it in 4 quarters since. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • BNP Paribas Asset Management held 1,665 shares of Avanos Medical worth $23.3K as of Q1 2026.
  • BNP Paribas Asset Management bought 490 Avanos Medical shares in Q1 2026, an estimated $6.6K.
  • Avanos Medical made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #1983 holding.
  • BNP Paribas Asset Management first reported a position in Avanos Medical in Q2 2025 and has held it in 4 quarters since.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.